AB Science has a unique and diversified indication portfolio that includes multiple late-stage programs.
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
Pipeline
You are here:
AB Science has a unique and diversified indication portfolio that includes multiple late-stage programs.